...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >alpha-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.
【24h】

alpha-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.

机译:α-突触核蛋白上调B103神经母细胞瘤细胞中Caveolin-1的表达并下调细胞外信号调节的激酶活性:在帕金森氏病发病机理中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

alpha-Synuclein accumulation plays an important role in the pathogenesis of Lewy body disease (LBD) and Parkinson's disease (PD). Although the mechanisms are not yet clear, it is possible that dysregulation of the extracellular signal-regulated kinase (ERK) might play a role. As caveolins form scaffolds onto which signaling molecules such as ERK can assemble, we propose that signaling alterations associated with alpha-synuclein accumulation and neurodegeneration, might be mediated via caveolae. Therefore, the objective of the present study was to investigate the potential contribution of alterations in the caveolar system in mediating alpha-synuclein effects on the ERK signaling pathway. For this, synuclein-transfected B103 neuroblastoma cells were used as a model system. In this cell line, caveolin-1 expression was up-regulated, whereas, ERK was down-regulated. ERK was weakly but consistently co-immunoprecipitated with alpha-synuclein but caveolin-1 did not co-immunoprecipitate with alpha-synuclein. Moreover, treatment of alpha-synuclein- overexpressing cells with caveolin-1 antisense oligonucleotides resulted in stimulation of ERK activity, with amelioration of the neuritic alterations. Transduction of alpha-synuclein-overexpressing cells, with an adenoviral vector directing the expression of ERK, resulted in suppression of caveolin-1 expression and re-establishment of the normal patterns of neurite outgrowth. These results suggest that alpha-synuclein may also interfere with ERK signaling by dysregulating caveolin-1 expression. Thus, the caveolin-1/ERK pathway could be a therapeutic target for the alpha-synuclein-related neurodegenerative disorders.
机译:α-突触核蛋白的积累在路易体病(LBD)和帕金森氏病(PD)的发病机理中起重要作用。尽管其机制尚不清楚,但细胞外信号调节激酶(ERK)的失调可能发挥了作用。由于小窝蛋白形成支架,信号传导分子(例如ERK)可以在其上组装,我们建议与α-突触核蛋白积累和神经变性相关的信号改变可能是通过小窝介导的。因此,本研究的目的是研究小窝系统改变在介导α-突触核蛋白对ERK信号通路的影响中的潜在作用。为此,将突触核蛋白转染的B103神经母细胞瘤细胞用作模型系统。在此细胞系中,caveolin-1的表达上调,而ERK的下调。 ERK较弱,但始终与α-突触核蛋白共同免疫沉淀,但Caveolin-1并未与α-突触核蛋白共同免疫沉淀。此外,用caveolin-1反义寡核苷酸处理过表达α-突触核蛋白的细胞可刺激ERK活性,并改善神经变性。用指导ERK表达的腺病毒载体转导过表达α-突触核蛋白的细胞,可抑制小窝蛋白1的表达并重建神经突增生的正常模式。这些结果表明α-突触核蛋白也可能通过异常调节caveolin-1表达来干扰ERK信号传导。因此,caveolin-1 / ERK途径可能是α-突触核蛋白相关的神经退行性疾病的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号